×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
This video will be soon available

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Organisé par

 

 

Programme

18:30
Les révolutions dans la prise en charge des cancers du sein HER2+
Pr Nicolas Isambert, Poitiers
 
18:40
Expression HER2 : hétérogénéité tumorale et conséquences en clinique
Dr Olivier Renaud, Poitiers

Discussion
 
19:10

Quelle prise en charge dans le cancer du sein HER2+ précoce actuelle et dans un futur proche ?
Dr Jean-Sébastien Frénel, Nantes

Discussion
 

19:40

Nouveaux algorithmes dans la prise en charge du cancer du sein HER2+
Dr Anthony Joncour, Poitiers

Discussion
 

20:10 Synthèse et conclusion
Pr Nicolas Isambert, Poitiers

 

Shooting date : 2021-10-07
Last update : 2021-10-08

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Honolulu : Thursday, November 27th 2025 from 08:30am to 10:30am (GMT+1)
San Francisco : Thursday, November 27th 2025 from 10:30am to 12:30pm (GMT+1)
New York : Thursday, November 27th 2025 from 01:30pm to 03:30pm (GMT+1)
Buenos Aires : Thursday, November 27th 2025 from 03:30pm to 05:30pm (GMT+1)
London / Dublin : Thursday, November 27th 2025 from 06:30pm to 08:30pm (GMT+1)
Paris / Berlin : Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Istanbul : Thursday, November 27th 2025 from 08:30pm to 10:30pm (GMT+1)
Moscou / Dubaï : Thursday, November 27th 2025 from 10:30pm to 12:30am (GMT+1)
Bangkok : Friday, November 28th 2025 from 01:30am to 03:30am (GMT+1)
Shanghai : Friday, November 28th 2025 from 02:30am to 04:30am (GMT+1)
Tokyo : Friday, November 28th 2025 from 03:30am to 05:30am (GMT+1)
Sydney : Friday, November 28th 2025 from 04:30am to 06:30am (GMT+1)
Wellington : Friday, November 28th 2025 from 06:30am to 08:30am (GMT+1)

Cancers du sein HER2- métastatiques

Que retenir pour la pratique de demain ?

Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, March 19th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, March 19th 2024 from 09am to 10:30am (GMT+1)
New York : Tuesday, March 19th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, March 19th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, March 19th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, March 19th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, March 20th 2024 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, March 20th 2024 from 05am to 06:30am (GMT+1)

Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, February 1st 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, February 1st 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, February 1st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, February 1st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, February 1st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, February 2nd 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, February 2nd 2024 from 05am to 06:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2-faible

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up